SOURCE: BioMedReports


June 10, 2010 07:55 ET

Earnings-Driven Story Should Drive Dramatic Stock Appreciation for ActiveCare

LOS ANGELES, CA--(Marketwire - June 10, 2010) - BioMedReports is reporting that, within days, ActiveCare (OTCBB: ACAR) is expecting to be able to announce some strategic partnerships that should have major revenue and earning implications.

The news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors is alerting its readers to this development because the growing use of personal emergency-alert systems, devices of potential benefit to millions of older people, is trending higher and this has attracted the attention of several potential partners to the company.

"Given the small number of shares available in the float, the appreciation in the stock price could be dramatic," reports healthcare sector stock analyst M.E. Garza.

"For a small portion of the cost of in-home care or assisted living facilities, seniors using ActiveCare (OTCBB: ACAR) can receive similar practical services, allowing them to have the confidence to continue living in the homes they love, knowing that they can get help whenever and wherever they need it." That according to a recent presentation about the company given by James Dalton, Chairman and CEO of ActiveCare -- a company which only began making its shares available to the public a few short months ago.

ActiveCare aims to offer useful, valuable and emergency services for aging adults while giving a sense of ease to those that care for them. ActiveCare's services are personalized and comprehensive while also helping to improve the lives of aging adults every day. From monitoring health to assisting with everyday needs, ActiveCare helps members live independently with greater security and peace of mind.

ActiveCare makes available a new line of services that provide aging individuals and their caregivers many conveniences similar to those offered by in-home care or assisted living, only at the touch of a button and at a fraction of the cost.

Investors can find the full report at BioMedReports.Com:

Biotech investors interested in accessing the news portal's complete database of clinical trials and upcoming FDA decisions can access that information here:

About BioMedReports.Com is a news portal covering the biomedical news and financial sector. BioMedReports is not paid or compensated to report the news and developments of publicly traded companies.

For more biomedical sector and investment news go to

Contact Information

  • Media Contacts Only:
    Mary Davila
    Assistant Editor
    e-mail: Email Contact
    Tel: +1 323 472 4480
    Fax: +1 888 210 3556